Literature DB >> 22270025

Neurodevelopmental disorders: Unsilencing dormant Ube3a--hope for Angelman syndrome?

Katy Malpass.   

Abstract

Entities:  

Year:  2012        PMID： 22270025     DOI： 10.1038/nrneurol.2012.2

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.

Authors:  Hsien-Sung Huang; John A Allen; Angela M Mabb; Ian F King; Jayalakshmi Miriyala; Bonnie Taylor-Blake; Noah Sciaky; J Walter Dutton; Hyeong-Min Lee; Xin Chen; Jian Jin; Arlene S Bridges; Mark J Zylka; Bryan L Roth; Benjamin D Philpot
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962
  1 in total
  2 in total

1.  Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse.

Authors:  Vipendra Kumar; Tripti Joshi; Naman Vatsa; Brijesh Kumar Singh; Nihar Ranjan Jana
Journal:  Front Mol Neurosci       Date:  2019-11-26       Impact factor: 5.639

Review 2.  Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.

Authors:  Nycole A Copping; Stephanie M McTighe; Kyle D Fink; Jill L Silverman
Journal:  Neurotherapeutics       Date:  2021-09-15       Impact factor: 7.620
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.